Mapping factors that affect access to addiction and pain treatment
Use of topic modeling and stakeholderengagement to map determinants of implementation disparities in addiction and pain research
This study is looking into why some people have a harder time getting help for addiction and pain, especially those in underserved communities, and it aims to find better ways to make sure everyone gets the right care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10987451 on NIH RePORTER |
What this research studies
This research investigates the reasons behind disparities in access to addiction and pain management treatments for underserved populations. It employs a combination of stakeholder engagement and machine learning techniques to create a health equity taxonomy that identifies and prioritizes the needs of these populations. By developing consistent methods and language for understanding health inequities, the research aims to improve the implementation of culturally-relevant interventions. Patients may benefit from enhanced access to tailored treatments that address their specific needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from historically underserved or marginalized communities who experience disparities in addiction and pain treatment.
Not a fit: Patients who do not belong to underserved populations or who do not experience disparities in access to treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access and quality of addiction and pain management treatments for marginalized populations.
How similar studies have performed: Other research has shown success in using stakeholder engagement and machine learning to address health disparities, making this approach promising yet innovative.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Mcgovern, Mark P — Stanford University
- Study coordinator: Mcgovern, Mark P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.